These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

981 related articles for article (PubMed ID: 33761654)

  • 1. Comorbidities' potential impacts on severe and non-severe patients with COVID-19: A systematic review and meta-analysis.
    Cheng S; Zhao Y; Wang F; Chen Y; Kaminga AC; Xu H
    Medicine (Baltimore); 2021 Mar; 100(12):e24971. PubMed ID: 33761654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.
    Yin T; Li Y; Ying Y; Luo Z
    BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Association between Presence of Comorbidities and COVID-19 Severity: A Systematic Review and Meta-Analysis.
    Honardoost M; Janani L; Aghili R; Emami Z; Khamseh ME
    Cerebrovasc Dis; 2021; 50(2):132-140. PubMed ID: 33530081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Features of severe COVID-19: A systematic review and meta-analysis.
    Del Sole F; Farcomeni A; Loffredo L; Carnevale R; Menichelli D; Vicario T; Pignatelli P; Pastori D
    Eur J Clin Invest; 2020 Oct; 50(10):e13378. PubMed ID: 32860457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardio-Cerebrovascular Disease is Associated With Severity and Mortality of COVID-19: A Systematic Review and Meta-Analysis.
    Yu JN; Wu BB; Yang J; Lei XL; Shen WQ
    Biol Res Nurs; 2021 Apr; 23(2):258-269. PubMed ID: 32851851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis.
    Yang J; Zheng Y; Gou X; Pu K; Chen Z; Guo Q; Ji R; Wang H; Wang Y; Zhou Y
    Int J Infect Dis; 2020 May; 94():91-95. PubMed ID: 32173574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
    Ge E; Li Y; Wu S; Candido E; Wei X
    PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis.
    Figliozzi S; Masci PG; Ahmadi N; Tondi L; Koutli E; Aimo A; Stamatelopoulos K; Dimopoulos MA; Caforio ALP; Georgiopoulos G
    Eur J Clin Invest; 2020 Oct; 50(10):e13362. PubMed ID: 32726868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis.
    Zhou Y; Yang Q; Chi J; Dong B; Lv W; Shen L; Wang Y
    Int J Infect Dis; 2020 Oct; 99():47-56. PubMed ID: 32721533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological characteristics of patients with severe COVID-19 infection in Wuhan, China: evidence from a retrospective observational study.
    Wang F; Cao J; Yu Y; Ding J; Eshak ES; Liu K; Mubarik S; Shi F; Wen H; Zeng Z; Bai J; Yu C
    Int J Epidemiol; 2021 Jan; 49(6):1940-1950. PubMed ID: 33150437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis.
    Gao Y; Chen Y; Liu M; Niu M; Song Z; Yan M; Tian J
    Epidemiol Infect; 2021 Feb; 149():e66. PubMed ID: 33583450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 and comorbidities: a systematic review and meta-analysis.
    Gold MS; Sehayek D; Gabrielli S; Zhang X; McCusker C; Ben-Shoshan M
    Postgrad Med; 2020 Nov; 132(8):749-755. PubMed ID: 32573311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia.
    Li J; He X; Yuan Yuan ; Zhang W; Li X; Zhang Y; Li S; Guan C; Gao Z; Dong G
    Am J Infect Control; 2021 Jan; 49(1):82-89. PubMed ID: 32540370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-existing cerebrovascular disease and poor outcomes of COVID-19 hospitalized patients: a meta-analysis.
    Patel U; Malik P; Shah D; Patel A; Dhamoon M; Jani V
    J Neurol; 2021 Jan; 268(1):240-247. PubMed ID: 32770412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular comorbidities as predictors for severe COVID-19 infection or death.
    Phelps M; Christensen DM; Gerds T; Fosbøl E; Torp-Pedersen C; Schou M; Køber L; Kragholm K; Andersson C; Biering-Sørensen T; Christensen HC; Andersen MP; Gislason G
    Eur Heart J Qual Care Clin Outcomes; 2021 Mar; 7(2):172-180. PubMed ID: 33107909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IMPACT OF COMORBIDITIES IN MEXICAN SARS-COV-2-POSITIVE PATIENTS: A RETROSPECTIVE ANALYSIS IN A NATIONAL COHORT.
    Kammar-García A; Vidal-Mayo JJ; Vera-Zertuche JM; Lazcano-Hernández M; Vera-López O; Segura-Badilla O; Aguilar-Alonso P; Navarro-Cruz AR
    Rev Invest Clin; 2020; 72(3):151-158. PubMed ID: 32584330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical symptoms, comorbidities and complications in severe and non-severe patients with COVID-19: A systematic review and meta-analysis without cases duplication.
    Wang Z; Deng H; Ou C; Liang J; Wang Y; Jiang M; Li S
    Medicine (Baltimore); 2020 Nov; 99(48):e23327. PubMed ID: 33235096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis.
    Baral R; Tsampasian V; Debski M; Moran B; Garg P; Clark A; Vassiliou VS
    JAMA Netw Open; 2021 Mar; 4(3):e213594. PubMed ID: 33787911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidities and complications of COVID-19 associated with disease severity, progression, and mortality in China with centralized isolation and hospitalization: A systematic review and meta-analysis.
    Chen Z; Peng Y; Wu X; Pang B; Yang F; Zheng W; Liu C; Zhang J
    Front Public Health; 2022; 10():923485. PubMed ID: 36052001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.